The effects of the PD teicoplanin therapy provided a clinical benefit for the primary composite endpoint in most subgroups except patients with primary infection site outside pneumonia, but the interaction effect did not reach statistical significance ( p for interaction = 0.299).
← all excerpts
Pharmacist-Driven Dosing Services and Pharmaceutical Care Increase Probability of Teicoplanin Target Concentration Attainment and Improve Clinical and Economic Outcomes in Non-Critically Ill Patients.
1
—
—